tiprankstipranks
Advertisement
Advertisement

ZLAB Stock Latest News

Zai Lab Announces Leadership Change as COO Departs
Company AnnouncementsZai Lab Announces Leadership Change as COO Departs
13d ago
8K
ZLAB
Zai Lab announces departure of COO Josh Smiley
PremiumThe Fly
Zai Lab announces departure of COO Josh Smiley
13d ago
ZLAB
Zai Lab receives FDA Fast Track Designation for zocilurtatug pelitecan
PremiumThe Fly
Zai Lab receives FDA Fast Track Designation for zocilurtatug pelitecan
24d ago
ZLAB
Zai Lab price target lowered to $44 from $47 at Citi
PremiumThe Fly
Zai Lab price target lowered to $44 from $47 at Citi
27d ago
ZLAB
Zai Lab reports Q1 EPS (4c), consensus (53c)
PremiumThe Fly
Zai Lab reports Q1 EPS (4c), consensus (53c)
28d ago
ZLAB
Zai Lab presents new preclinical data on ZL-1503
PremiumThe FlyZai Lab presents new preclinical data on ZL-1503
2M ago
ZLAB
Zai Lab to present zocilurtatug pelitecan clinical data at AACR meeting
Premium
The Fly
Zai Lab to present zocilurtatug pelitecan clinical data at AACR meeting
2M ago
ZLAB
Zai Lab, Amgen announces trial agreement to evaluate zocilurtatug pelitecan
Premium
The Fly
Zai Lab, Amgen announces trial agreement to evaluate zocilurtatug pelitecan
2M ago
AMGN
ZLAB
Zai Lab price target lowered to $32 from $39 at JPMorgan
PremiumThe Fly
Zai Lab price target lowered to $32 from $39 at JPMorgan
3M ago
ZLAB
Zai Lab Advances DLLEVATE Trial In Relapsed Small Cell Lung Cancer
PremiumCompany Announcements
Zai Lab Advances DLLEVATE Trial In Relapsed Small Cell Lung Cancer
3M ago
ZLAB
Zai Lab: Validated Povetacicept Data and China IgAN Opportunity Support Upside and Buy Rating
PremiumRatings
Zai Lab: Validated Povetacicept Data and China IgAN Opportunity Support Upside and Buy Rating
3M ago
ZLAB
Zai Lab Earnings Call: Growth, Pipeline And Volatility
PremiumCompany Announcements
Zai Lab Earnings Call: Growth, Pipeline And Volatility
3M ago
ZLAB
Zai Lab price target lowered to $37 from $55 at Cantor Fitzgerald
PremiumThe FlyZai Lab price target lowered to $37 from $55 at Cantor Fitzgerald
3M ago
ZLAB
Zai Lab price target lowered to $47 from $53 at Citi
Premium
The Fly
Zai Lab price target lowered to $47 from $53 at Citi
3M ago
ZLAB
Zai Lab reports Q4 EPS (46c), consensus (42c)
Premium
The Fly
Zai Lab reports Q4 EPS (46c), consensus (42c)
3M ago
ZLAB
Zai Lab price target lowered to $53 from $58 at Citi
PremiumThe Fly
Zai Lab price target lowered to $53 from $58 at Citi
3M ago
ZLAB
Zai Lab Advances New Solid Tumor Drug ZL-1310: What Investors Should Watch
PremiumCompany Announcements
Zai Lab Advances New Solid Tumor Drug ZL-1310: What Investors Should Watch
4M ago
ZLAB
Zai Lab’s ZL-6201 Study Advances in Sarcoma and Solid Tumors: What Investors Should Watch
PremiumCompany Announcements
Zai Lab’s ZL-6201 Study Advances in Sarcoma and Solid Tumors: What Investors Should Watch
4M ago
ZLAB
Zai Lab price target lowered to $39 from $46 at JPMorgan
PremiumThe Fly
Zai Lab price target lowered to $39 from $46 at JPMorgan
4M ago
ZLAB
Zai Lab initiated with a Buy at UBS
PremiumThe FlyZai Lab initiated with a Buy at UBS
5M ago
ZLAB
Zai Lab announces China NMPA approval for Augtryo sNDA
Premium
The Fly
Zai Lab announces China NMPA approval for Augtryo sNDA
5M ago
ZLAB
Zai Lab rises 7.4%
Premium
The Fly
Zai Lab rises 7.4%
5M ago
ZLAB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >